Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study
Abstract Background Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) carry significant morbidity and mortality. AECOPD treatment remains limited. High molecular weight hyaluronan (HMW-HA) is a glycosaminoglycan sugar, which is a physiological constituent of the lung extracellula...
Main Authors: | Flavia Galdi, Claudio Pedone, Christopher A. McGee, Margaret George, Annette B. Rice, Shah S. Hussain, Kadambari Vijaykumar, Evan R. Boitet, Guillermo J. Tearney, John A. McGrath, Audrey R. Brown, Steven M. Rowe, Raffaele A. Incalzi, Stavros Garantziotis |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-02-01
|
Series: | Respiratory Research |
Online Access: | https://doi.org/10.1186/s12931-020-01610-x |
Similar Items
-
The Rise and Fall of Hyaluronan in Respiratory Diseases
by: Mark E. Lauer, et al.
Published: (2015-01-01) -
Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology
by: Jaime M. Cyphert, et al.
Published: (2015-01-01) -
Intravascular heavy chain-modification of hyaluronan during endotoxic shock
by: Kevin Ni, et al.
Published: (2019-03-01) -
The Importance of Inhaler Adherence to Prevent COPD Exacerbations
by: Jose R. Jardim, et al.
Published: (2019-04-01) -
Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP.
by: Zhuowei Li, et al.
Published: (2011-01-01)